Mineralys Therapeutics
Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States. The company's clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly s...
Mineralys Therapeutics Logo
About Mineralys Therapeutics
Mineralys Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Mineralys Therapeutics offers aldosterone synthase inhibitor (ASI) that we are initially developing for the treatment of patients with uncontrolled hypertension.
Address
150 N. Radnor Chester Rd., Suite F200
Radnor, 19087
United States
Year founded
2019
Number of employees
0-100
Report inaccurate data
Request an update to help us keep the brand up-to-date.
